1 of 5000

|

acrylic prints sign acrylic prints science acrylic prints medical acrylic prints medicine acrylic prints breast acrylic prints breast implant acrylic prints anaplastic large cell lymphoma acrylic prints lymphoma acrylic prints cancer acrylic prints food and drug administration acrylic prints fda acrylic prints illustration acrylic prints infographic acrylic prints signage acrylic prints caution acrylic prints

photographs sign photos science photos medical photos medicine photos breast photos breast implant photos anaplastic large cell lymphoma photos lymphoma photos cancer photos food and drug administration photos fda photos illustration photos infographic photos signage photos caution photos

Add This Artwork to Your Favorites Collection

Comment

Add This Artwork to Your Favorites Collection

Comment

This illustration shows the typical location of the ALCL that was diagnosed in patients with breast implants. ALCL is lymphoma, a type of cancer involving cells of the immune system. It is not cancer of the breast tissue. After an intensive review of known cases of a rare form of cancer in breast implant recipients, the Food and Drug Administration (FDA) says women with implants may have a very small, but increased risk of developing anaplastic large cell lymphoma, or ALCL. FDA scientists reached that conclusion after examining scientific literature that focused on cases of ALCL in 34 women with breast implants, as well as information from agency reports, international regulatory agencies, scientific experts, and breast implant manufacturers.